Latest ACUTA CAPITAL PARTNERS, LLC Stock Portfolio
ACUTA CAPITAL PARTNERS, LLC Performance:
2025 Q2: 10.12%YTD: -0.33%2024: 20.66%
Performance for 2025 Q2 is 10.12%, and YTD is -0.33%, and 2024 is 20.66%.
About ACUTA CAPITAL PARTNERS, LLC and 13F Hedge Fund Stock Holdings
In it's latest 13F Holdings report, ACUTA CAPITAL PARTNERS, LLC reported an equity portfolio of $71.6 Millions as of 30 Jun, 2025.
The top stock holdings of ACUTA CAPITAL PARTNERS, LLC are OCUL, CDTX, AADI. The fund has invested 13.2% of it's portfolio in OCULAR THERAPEUTIX INC and 12.2% of portfolio in CIDARA THERAPEUTICS INC.
The fund managers got completely rid off ENLIVEN THERAPEUTICS INC, MERCK & CO (MRK) and EDGEWISE THERAPEUTICS INC (EWTX) stocks. They significantly reduced their stock positions in INSMED INC (INSM), LIQUIDIA CORPORATION (LQDA) and TREVI THERAPEUTICS INC (TRVI). ACUTA CAPITAL PARTNERS, LLC opened new stock positions in TAYSHA GENE THERAPIES INC (TSHA), AKERO THERAPEUTICS INC (AKRO) and FULCRUM THERAPEUTICS INC (FULC). The fund showed a lot of confidence in some stocks as they added substantially to JAZZ PHARMACEUTICALS PLC (JAZZ), CIDARA THERAPEUTICS INC (CDTX) and TERNS PHARMACEUTICALS INC (TERN).
The top stock holdings of ACUTA CAPITAL PARTNERS, LLC are OCUL, CDTX, AADI. The fund has invested 13.2% of it's portfolio in OCULAR THERAPEUTIX INC and 12.2% of portfolio in CIDARA THERAPEUTICS INC.
The fund managers got completely rid off ENLIVEN THERAPEUTICS INC, MERCK & CO (MRK) and EDGEWISE THERAPEUTICS INC (EWTX) stocks. They significantly reduced their stock positions in INSMED INC (INSM), LIQUIDIA CORPORATION (LQDA) and TREVI THERAPEUTICS INC (TRVI). ACUTA CAPITAL PARTNERS, LLC opened new stock positions in TAYSHA GENE THERAPIES INC (TSHA), AKERO THERAPEUTICS INC (AKRO) and FULCRUM THERAPEUTICS INC (FULC). The fund showed a lot of confidence in some stocks as they added substantially to JAZZ PHARMACEUTICALS PLC (JAZZ), CIDARA THERAPEUTICS INC (CDTX) and TERNS PHARMACEUTICALS INC (TERN).
ACUTA CAPITAL PARTNERS, LLC Annual Return Estimates Vs S&P 500
Our best estimate is that ACUTA CAPITAL PARTNERS, LLC made a return of 10.12% in the last quarter. In trailing 12 months, it's portfolio return was 5.49%.
New Buys
| Ticker | $ Bought |
|---|---|
| taysha gene therapies inc | 1,121,900 |
| akero therapeutics inc | 1,055,030 |
| fulcrum therapeutics inc | 410,392 |
| unicycive therapeutics inc | 300,028 |
New stocks bought by ACUTA CAPITAL PARTNERS, LLC
Additions
| Ticker | % Inc. |
|---|---|
| jazz pharmaceuticals plc | 174 |
| cidara therapeutics inc | 42.85 |
| terns pharmaceuticals inc | 42.49 |
| zymeworks inc | 22.2 |
| rapport therapeutics inc | 21.95 |
| ultragenyx pharmaceutical inc | 11.86 |
Additions to existing portfolio by ACUTA CAPITAL PARTNERS, LLC
Reductions
| Ticker | % Reduced |
|---|---|
| insmed inc | -65.05 |
| liquidia corporation | -50.56 |
| trevi therapeutics inc | -37.18 |
| tourmaline bio inc | -33.55 |
| bright minds biosciences inc | -18.87 |
| ocular therapeutix inc | -16.79 |
| revolution medicines inc | -16.45 |
| praxis precision medicines i | -14.98 |
ACUTA CAPITAL PARTNERS, LLC reduced stake in above stock
Sold off
| Ticker | $ Sold |
|---|---|
| mereo biopharma group pl-adr | -1,781,580 |
| enliven therapeutics inc | -5,220,490 |
| unicycive therapeutics inc | -1,352,680 |
| verve therapeutics inc | -743,649 |
| enliven therapeutics inc | 0.00 |
| edgewise therapeutics inc | -1,879,990 |
| rocket pharmaceuticals inc | -555,945 |
| merck & co | -2,063,940 |
ACUTA CAPITAL PARTNERS, LLC got rid off the above stocks
Sector Distribution
ACUTA CAPITAL PARTNERS, LLC has about 73.8% of it's holdings in Healthcare sector.
| Sector | % |
|---|---|
| Healthcare | 73.8 |
| Others | 26.2 |
Market Cap. Distribution
ACUTA CAPITAL PARTNERS, LLC has about 5.2% of it's portfolio invested in the large-cap and mega-cap stocks.
| Category | % |
|---|---|
| SMALL-CAP | 32.3 |
| UNALLOCATED | 26.2 |
| MICRO-CAP | 16.9 |
| NANO-CAP | 11.4 |
| MID-CAP | 8 |
| LARGE-CAP | 5.2 |
Stocks belong to which Index?
About 40.6% of the stocks held by ACUTA CAPITAL PARTNERS, LLC either belong to S&P 500 or RUSSELL 2000 index.
| Index | % |
|---|---|
| Others | 59.4 |
| RUSSELL 2000 | 40.6 |
ACUTA CAPITAL PARTNERS, LLC Holdings Map
This heatmap illustrates the top 50 positions within the fund's portfolio.
Current Stock Holdings of ACUTA CAPITAL PARTNERS, LLC
ACUTA CAPITAL PARTNERS, LLC has 28 stocks in it's portfolio. About 72.1% of the portfolio is in top 10 stocks. TRVI proved to be the most loss making stock for the portfolio. CDTX was the most profitable stock for ACUTA CAPITAL PARTNERS, LLC last quarter.
Last Reported on: 14 Aug, 2025| Ticker | Namesorted ascending | % Portfolio | Shares Held | $ Value | Type | % Change | Options | |
|---|---|---|---|---|---|---|---|---|
| AADI | whitehawk therapeutics inc | 8.90 | 3,410,400 | 6,377,450 | unchanged | 0.00 | ||
| AKRO | akero therapeutics inc | 1.47 | 19,772 | 1,055,030 | new | |||
| CDTX | cidara therapeutics inc | 12.21 | 179,569 | 8,746,810 | added | 42.85 | ||
| EWTX | edgewise therapeutics inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| FBRX | forte biosciences inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| FULC | fulcrum therapeutics inc | 0.57 | 59,650 | 410,392 | new | |||
| GILD | gilead sciences inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| INSM | insmed inc | 5.21 | 37,070 | 3,730,720 | reduced | -65.05 | ||
| JAZZ | jazz pharmaceuticals plc | 3.89 | 26,283 | 2,789,150 | added | 174 | ||
| LQDA | liquidia corporation | 1.32 | 75,876 | 945,415 | reduced | -50.56 | ||
| MREO | mereo biopharma group pl-adr | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| MRK | merck & co | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| NUVB | nuvation bio inc -cw27 | 0.03 | 90,832 | 24,516 | unchanged | 0.00 | ||
| OCUL | ocular therapeutix inc | 13.15 | 1,014,940 | 9,418,640 | reduced | -16.79 | ||
| PRAX | praxis precision medicines i | 4.35 | 74,087 | 3,115,360 | reduced | -14.98 | ||
| RARE | ultragenyx pharmaceutical inc | 1.21 | 23,814 | 865,877 | added | 11.86 | ||
| RCKT | rocket pharmaceuticals inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| RVMD | revolution medicines inc | 2.86 | 55,693 | 2,048,940 | reduced | -16.45 | ||
| SLNO | soleno therapeutics inc | 7.42 | 63,436 | 5,314,670 | reduced | -5.51 | ||
| SRZN | surrozen, inc. | 2.12 | 170,000 | 1,519,800 | unchanged | 0.00 | ||